• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用编码严重急性呼吸综合征冠状病毒刺突基因片段的质粒DNA免疫的小鼠体液反应的特征分析。

Characterization of humoral responses in mice immunized with plasmid DNAs encoding SARS-CoV spike gene fragments.

作者信息

Zeng Fanya, Chow Ken Yan Ching, Hon Chung Chau, Law Ka Man, Yip Chi Wai, Chan Kwok Hung, Peiris Joseph S Malik, Leung Frederick Chi Ching

机构信息

Department of Zoology, The University of Hong Kong, Pokfulam Rd, Hong Kong, SAR, China.

出版信息

Biochem Biophys Res Commun. 2004 Mar 19;315(4):1134-9. doi: 10.1016/j.bbrc.2004.01.166.

DOI:10.1016/j.bbrc.2004.01.166
PMID:14985131
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7111006/
Abstract

The immunological characteristics of SARS-CoV spike protein were investigated by administering mice with plasmids encoding various S gene fragments. We showed that the secreting forms of S1, S2 subunits and the N-terminus of S1 subunit (residues 18-495) were capable of eliciting SARS-CoV specific antibodies and the region immediate to N-terminus of matured S1 protein contained an important immunogenic determinant for elicitation of SARS-CoV specific antibodies. In addition, mice immunized with plasmids encoding S1 fragment developed a Th1-mediated antibody isotype switching. Another interesting finding was that mouse antibodies elicited separately by plasmids encoding S1 and S2 subunits cooperatively neutralized SARS-CoV but neither the S1 nor S2 specific antibodies did, suggesting the possible role of both S1 and S2 subunits in host cell docking and entry. These results provide insights into understanding the immunological characteristics of spike protein and the development of subunit vaccines against SARS-CoV.

摘要

通过给小鼠注射编码各种S基因片段的质粒,研究了SARS-CoV刺突蛋白的免疫特性。我们发现,S1、S2亚基以及S1亚基的N端(第18-495位氨基酸)的分泌形式能够引发SARS-CoV特异性抗体,并且成熟S1蛋白紧邻N端的区域包含一个引发SARS-CoV特异性抗体的重要免疫原性决定簇。此外,用编码S1片段的质粒免疫的小鼠发生了Th1介导的抗体亚型转换。另一个有趣的发现是,分别由编码S1和S2亚基的质粒引发的小鼠抗体协同中和SARS-CoV,但单独的S1或S2特异性抗体则不能,这表明S1和S2亚基在宿主细胞对接和进入过程中可能发挥作用。这些结果为理解刺突蛋白的免疫特性以及开发针对SARS-CoV的亚单位疫苗提供了思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/320b/7111006/0872163316f7/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/320b/7111006/0f61578804da/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/320b/7111006/94631c072989/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/320b/7111006/0872163316f7/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/320b/7111006/0f61578804da/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/320b/7111006/94631c072989/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/320b/7111006/0872163316f7/gr3.jpg

相似文献

1
Characterization of humoral responses in mice immunized with plasmid DNAs encoding SARS-CoV spike gene fragments.用编码严重急性呼吸综合征冠状病毒刺突基因片段的质粒DNA免疫的小鼠体液反应的特征分析。
Biochem Biophys Res Commun. 2004 Mar 19;315(4):1134-9. doi: 10.1016/j.bbrc.2004.01.166.
2
[Potent neutralization antibody elicited in mice by SARS-associated coronavirus spike protein S1 domain].[严重急性呼吸综合征相关冠状病毒刺突蛋白S1结构域在小鼠体内引发的强效中和抗体]
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2004 Sep;18(3):258-60.
3
Production of a monoclonal antibody against SARS-CoV spike protein with single intrasplenic immunization of plasmid DNA.通过质粒DNA单次脾内免疫制备抗SARS-CoV刺突蛋白的单克隆抗体。
Immunol Lett. 2005 Sep 15;100(2):177-81. doi: 10.1016/j.imlet.2005.03.015.
4
Construction of a eukaryotic expression plasmid encoding partial S gene fragments of the SARS-CoV and its potential utility as a DNA vaccine.严重急性呼吸综合征冠状病毒(SARS-CoV)部分S基因片段真核表达质粒的构建及其作为DNA疫苗的潜在应用
DNA Cell Biol. 2005 Aug;24(8):516-20. doi: 10.1089/dna.2005.24.516.
5
Elicitation of immunity in mice after immunization with the S2 subunit of the severe acute respiratory syndrome coronavirus.用严重急性呼吸综合征冠状病毒的S2亚基免疫小鼠后诱导免疫反应。
DNA Cell Biol. 2005 Aug;24(8):510-5. doi: 10.1089/dna.2005.24.510.
6
Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design.重组杆状病毒表达的严重急性呼吸综合征冠状病毒刺突蛋白的抗原性和免疫原性特征:对疫苗设计的启示
J Virol. 2006 Jun;80(12):5757-67. doi: 10.1128/JVI.00083-06.
7
SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus.以来自大肠杆菌的重组刺突多肽作为加强剂的严重急性呼吸综合征冠状病毒刺突多肽DNA疫苗初免可诱导产生高滴度的抗严重急性呼吸综合征冠状病毒中和抗体。
Vaccine. 2005 Oct 10;23(42):4959-68. doi: 10.1016/j.vaccine.2005.05.023.
8
Induction of specific immune responses by severe acute respiratory syndrome coronavirus spike DNA vaccine with or without interleukin-2 immunization using different vaccination routes in mice.在小鼠中使用不同接种途径,通过严重急性呼吸综合征冠状病毒刺突DNA疫苗联合或不联合白细胞介素-2免疫诱导特异性免疫反应。
Clin Vaccine Immunol. 2007 Jul;14(7):894-901. doi: 10.1128/CVI.00019-07. Epub 2007 May 9.
9
A chimeric multi-epitope DNA vaccine elicited specific antibody response against severe acute respiratory syndrome-associated coronavirus which attenuated the virulence of SARS-CoV in vitro.一种嵌合多表位DNA疫苗引发了针对严重急性呼吸综合征相关冠状病毒的特异性抗体反应,该反应在体外减弱了SARS-CoV的毒力。
Immunol Lett. 2008 Aug 15;119(1-2):71-7. doi: 10.1016/j.imlet.2008.04.005. Epub 2008 May 19.
10
Optimization of a DNA vaccine against SARS.一种抗非典DNA疫苗的优化
DNA Cell Biol. 2007 Oct;26(10):721-6. doi: 10.1089/dna.2007.0616.

引用本文的文献

1
Immunogenicity of SARS-CoV-2 Trimeric Spike Protein Associated to Poly(I:C) Plus Alum.SARS-CoV-2 三聚体刺突蛋白与 Poly(I:C) 加铝佐剂的免疫原性。
Front Immunol. 2022 Jun 30;13:884760. doi: 10.3389/fimmu.2022.884760. eCollection 2022.
2
Safety and Efficacy of Combined Intramuscular/Intranasal RAZI-COV PARS Vaccine Candidate Against SARS-CoV-2: A Preclinical Study in Several Animal Models.联合肌内/鼻内 RAZI-COV 疫苗候选物对 SARS-CoV-2 的安全性和有效性:几种动物模型的临床前研究。
Front Immunol. 2022 May 26;13:836745. doi: 10.3389/fimmu.2022.836745. eCollection 2022.
3
Induction of Potent and Durable Neutralizing Antibodies Against SARS-CoV-2 Using a Receptor Binding Domain-Based Immunogen.

本文引用的文献

1
Intramuscular and intradermal injection of DNA vaccines in mice and primates.在小鼠和灵长类动物中进行DNA疫苗的肌肉注射和皮内注射。
Methods Mol Med. 2000;29:71-7. doi: 10.1385/1-59259-688-6:71.
2
Detection of SARS coronavirus in patients with suspected SARS.疑似严重急性呼吸综合征(SARS)患者中SARS冠状病毒的检测
Emerg Infect Dis. 2004 Feb;10(2):294-9. doi: 10.3201/eid1002.030610.
3
Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome.引起严重急性呼吸综合征的新型冠状病毒的分子流行病学
基于受体结合域的免疫原诱导针对 SARS-CoV-2 的强效和持久中和抗体
Front Immunol. 2021 Mar 11;12:637982. doi: 10.3389/fimmu.2021.637982. eCollection 2021.
4
Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection.用于预防严重急性呼吸综合征冠状病毒 2 感染的临床开发疫苗制剂。
Adv Drug Deliv Rev. 2021 Feb;169:168-189. doi: 10.1016/j.addr.2020.12.006. Epub 2020 Dec 13.
5
Genomes: How Genomic Information has been Used to Deal with Past Outbreaks and the COVID-19 Pandemic.基因组:基因组信息如何用于应对过去的疫情爆发和 COVID-19 大流行。
Int J Mol Sci. 2020 Jun 26;21(12):4546. doi: 10.3390/ijms21124546.
6
Vaccination strategies to combat novel corona virus SARS-CoV-2.应对新型冠状病毒 SARS-CoV-2 的疫苗接种策略。
Life Sci. 2020 Sep 1;256:117956. doi: 10.1016/j.lfs.2020.117956. Epub 2020 Jun 12.
7
From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development.从 SARS-CoV 到 SARS-CoV-2:冠状病毒疫苗开发的安全性和广谱性很重要。
Microbes Infect. 2020 Jul-Aug;22(6-7):245-253. doi: 10.1016/j.micinf.2020.05.004. Epub 2020 May 11.
8
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV).严重急性呼吸综合征冠状病毒(SARS-CoV)
Perspect Med Virol. 2006;16:43-95. doi: 10.1016/S0168-7069(06)16004-8. Epub 2006 Nov 28.
9
Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses.针对新兴致病性人类冠状病毒的亚单位疫苗
Front Microbiol. 2020 Feb 28;11:298. doi: 10.3389/fmicb.2020.00298. eCollection 2020.
10
Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs.金纳米颗粒佐剂 S 蛋白诱导针对严重急性呼吸综合征相关冠状病毒感染的强烈抗原特异性 IgG 反应,但不能诱导保护性抗体并限制肺部嗜酸性粒细胞浸润。
Microbiol Immunol. 2020 Jan;64(1):33-51. doi: 10.1111/1348-0421.12754. Epub 2019 Nov 18.
Lancet. 2004 Jan 10;363(9403):99-104. doi: 10.1016/s0140-6736(03)15259-2.
4
Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.严重急性呼吸综合征疫苗研发:针对禽传染性支气管炎冠状病毒的疫苗接种经验
Avian Pathol. 2003 Dec;32(6):567-82. doi: 10.1080/03079450310001621198.
5
A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2.严重急性呼吸综合征冠状病毒S蛋白的一个193个氨基酸的片段可有效结合血管紧张素转换酶2。
J Biol Chem. 2004 Jan 30;279(5):3197-201. doi: 10.1074/jbc.C300520200. Epub 2003 Dec 11.
6
Effects of a SARS-associated coronavirus vaccine in monkeys.一种与非典相关的冠状病毒疫苗对猴子的影响。
Lancet. 2003 Dec 6;362(9399):1895-6. doi: 10.1016/S0140-6736(03)14962-8.
7
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.血管紧张素转换酶2是严重急性呼吸综合征冠状病毒的功能性受体。
Nature. 2003 Nov 27;426(6965):450-4. doi: 10.1038/nature02145.
8
Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003.2003年2月中华人民共和国广东省严重急性呼吸综合征(SARS)的流行病学及病因
Lancet. 2003 Oct 25;362(9393):1353-8. doi: 10.1016/s0140-6736(03)14630-2.
9
Prevalence of IgG antibody to SARS-associated coronavirus in animal traders--Guangdong Province, China, 2003.2003年中国广东省动物交易商中抗SARS相关冠状病毒IgG抗体的流行情况
MMWR Morb Mortal Wkly Rep. 2003 Oct 17;52(41):986-7.
10
Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy.人类免疫缺陷病毒1型与严重急性呼吸综合征冠状病毒之间隐含的相似性提示了一种抗严重急性呼吸综合征的策略。
BMC Microbiol. 2003 Sep 21;3:20. doi: 10.1186/1471-2180-3-20.